We recognize that our clients go through an ever-evolving development process and the need for short-term subject matter expertise to guide these decisions is critical.
- Novel ideas launching out of academia moving through proof-of-concept phases.
- Early-stage financing challenges – Investor preparation and pitch deck development
- Preclinical and Clinical Program advancement decisions
Commercial readiness and launch strategies
- Next Stage Financing – IPO Readiness
- Regulatory hurdles, Global Development Strategies
Domain Expertise: Therapeutics, Diagnostics, Pharma Services, Digital Medicine, Non-Profit Research
Leadership Expertise: CEO, CMO, CFO, CTO, CDO
Therapeutic Area Expertise: Oncology, Neurosciences, CVMD, ID, Digital / Precision Medicine